Notes
Ethiopia, Kenya, Malawi, Mozambique, Nigeria, South Africa, Tanzania, Uganda, Zambia and Zimbabwe
US dollars
Reference
Hontelez JA, et al. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness. AIDS : 29 Jun 2016. Available from: URL: http://doi.org/10.1097/QAD.0000000000001190
Rights and permissions
About this article
Cite this article
ART at any CD4 cell count cost effective in sub-Sahara. PharmacoEcon Outcomes News 757, 5 (2016). https://doi.org/10.1007/s40274-016-3194-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3194-y